Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2-expressing salivary gland carcinoma: a pooled analysis of two phase I studies.

Shunji TakahashiHideaki BandoIchiro KinoshitaShanu ModiJunji TsurutaniYung-Jue BangYuta SatoShunsuke NakataniCaleb LeeMasahiro SugiharaYasuyuki OkudaHiroji Iwata

Published in: Japanese journal of clinical oncology (2024)

FIH study, NCT02564900; DDI study, NCT03383692.

Keyphrases

epidermal growth factor receptor
tyrosine kinase
endothelial cells
advanced non small cell lung cancer
randomized controlled trial
induced pluripotent stem cells